Skip to main content
Industry News
Regeneron seeks EUA for antibody cocktail

Regeneron Pharmaceuticals said it has filed an application with the FDA seeking emergency use authorization for the experimental antibody cocktail used to treat President Donald Trump for COVID-19. If granted an EUA, the company said it has doses for 50,000 people available and expects to be able to treat 300,000 within a few months.

Full Story: